These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8518855)

  • 1. Influence of ionic strength on crystal adsorption and inhibitory activity of macromolecules.
    Utsunomiya M; Koide T; Yoshioka T; Yamaguchi S; Okuyama A
    Br J Urol; 1993 May; 71(5):516-22. PubMed ID: 8518855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory activity of human urine on calcium oxalate crystal growth: effects of sodium urate and uric acid.
    Fellström B; Backman U; Danielson BG; Holmgren K; Ljunghall S; Wikström B
    Clin Sci (Lond); 1982 May; 62(5):509-14. PubMed ID: 7075148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.
    Yamaguchi S; Yoshioka T; Utsunomiya M; Koide T; Osafune M; Okuyama A; Sonoda T
    Urol Res; 1993 May; 21(3):187-92. PubMed ID: 8342253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation.
    Ryall RL; Harnett RM; Marshall VR
    J Urol; 1986 Jan; 135(1):174-7. PubMed ID: 3079836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength.
    Fellström B; Lindsjö M; Danielson BG; Karlsson FA; Ljunghall S
    Clin Chim Acta; 1989 Apr; 180(3):213-220. PubMed ID: 2472910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.
    Wesson JA; Ganne V; Beshensky AM; Kleinman JG
    Urol Res; 2005 Jun; 33(3):206-12. PubMed ID: 15864572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine.
    Edyvane KA; Hibberd CM; Harnett RM; Marshall VR; Ryall RL
    Clin Chim Acta; 1987 Aug; 167(3):329-38. PubMed ID: 3621616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paradoxical role of urinary macromolecules in the aggregation of calcium oxalate: a further plea to increase diuresis in stone metaphylaxis.
    Baumann JM; Affolter B
    Urolithiasis; 2016 Aug; 44(4):311-7. PubMed ID: 26920852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the incorporation of urinary macromolecules onto crystals of different mineral compositions.
    Morse RM; Resnick MI
    J Urol; 1989 Mar; 141(3):641-4. PubMed ID: 2918609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine.
    Robertson WG; Scurr DS
    J Urol; 1986 Jun; 135(6):1322-6. PubMed ID: 2423714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibitory effects of Takusha on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Kawamura K; Moriyama M; Nakajima C; Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1993 Aug; 39(8):695-700. PubMed ID: 8379469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces.
    Leal JJ; Finlayson B
    Invest Urol; 1977 Jan; 14(4):278-83. PubMed ID: 64463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the surface conditioning of calcium-salt crystals treated with physiological and alkaline urine.
    Santin M; Motta A; Cannas M
    Br J Urol; 1998 Jul; 82(1):97-103. PubMed ID: 9698669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.